Everest Organics informs about disclosure

20 Mar 2025 Evaluate
Everest Organics has informed that the Company has received Trading approval for 17,10,526 Equity shares of Rs 10 each issued on preferential basis from BSE and the equity shares are admitted to dealing on the Exchange with effect from Thursday, March 20, 2025. The approval letter received from BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Everest Organics Share Price

406.50 2.50 (0.62%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×